全球口蹄疫市場規模、佔有率、成長分析，按技術（傳統疫苗（氫氧化鋁/皂苷疫苗、油基疫苗）），按動物類型（牛、綿羊和山羊） - 行業預測 2024-2031

Global FMD Disease Market Size, Share, Growth Analysis, By Technique(Conventional Vaccines (Aluminum Hydroxide/Saponin-based Vaccines, Oil-based Vaccines)), By Animal Type(Cattle, Sheep and goat) - Industry Forecast 2024-2031

出版日期: 2024年04月06日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022 年，全球口蹄疫疾病市場規模為 23.9 億美元，預計將從 2023 年的 25.8 億美元成長到 2031 年的 48.2 億美元，預測期內（2024-2031 年）複合年成長率為 8.1%。

由於對動物產品的需求增加和動物數量的增加，全球對獸用疫苗的採用，特別是那些旨在對抗口蹄疫（FMD）的疫苗，出現了顯著成長。這種激增可歸因於近年來受環境變遷和快速全球化等因素影響，牲畜和人畜共通傳染病的盛行率上升。這些因素在推動獸用疫苗市場方面發揮了重要作用，因為世界各國政府優先考慮對各種動物（包括公共動物和牲畜物種）採取安全醫療實踐。針對人畜共通病原體的立法在已開發國家和發展中國家均有效，並認知到疫情爆發對國家國內生產毛額 (GDP) 可能造成的嚴重經濟後果。減輕這些風險的措施包括撲殺受感染的動物和保持足夠的更新株的疫苗庫存。在對牛奶、雞蛋、肉類和織物等產品的需求不斷成長的推動下，畜牧業呈現強勁成長，吸引了對先進機械和現代技術的大量投資。鑑於與疾病爆發相關的巨大經濟損失，政府和畜牧業私人利益相關者認為針對口蹄疫的預防措施（例如疫苗接種）至關重要。缺乏明確的治癒方法凸顯了疫苗接種的重要性，特別是考慮到感染可能透過多種方式發生。在畜牧業生產對 GDP 貢獻顯著的發展中國家，動物保健實踐受到相當多的關注。這些國家的政府組織優先考慮開發新藥物和疫苗接種計劃，以保障牛隻的健康。相反，對動物流動採取嚴格措施和限制的地區，特別是北美和歐洲等富裕地區，有效地減少了口蹄疫的爆發，從而減少了對口蹄疫疫苗的依賴。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- MEA 的其餘部分

競爭格局

前 5 名企業比較
2021 年關鍵參與者的市場定位
主要市場參與者所採取的策略
最佳制勝策略
近期市集活動
主要公司市佔率（%），2021年

主要公司簡介

MSD Animal Health
Zoetis
Boehringer Ingelheim
Bayer AG
Indian Immunologicals Ltd.
Biogenesis-Bago
Ceva SantA(C) Animale
China Animal Husbandry Co., Ltd. (CAH)
Guangdong Dahuanong Animal Health Products Co., Ltd.
Heska Corporation
Indian Immunologicals Limited
Lanzhou Veterinary Research Institute
Limor de Colombia SA
Merial (Sanofi)
Minnesota Veterinary Diagnostic Laboratory
PVT-Polish Veterinary Pharmaceuticals Ltd.
RAKARB Veterinary Biotech.
Vecol SA
VA(C)toquinol
Bioveta as

簡介目錄

Product Code: SQMIG35E2021

Global FMD disease market size was valued at USD 2.39 billion in 2022 and is poised to grow from USD 2.58 billion in 2023 to USD 4.82 billion by 2031, at a CAGR of 8.1% during the forecast period (2024-2031).

The global adoption of veterinary vaccines, particularly those aimed at combating Foot-and-Mouth Disease (FMD), has experienced significant growth due to the increased demand for animal products and a larger population of animals. This surge can be attributed to the heightened prevalence of livestock and zoonotic diseases in recent years, influenced by factors such as environmental changes and rapid globalization. These factors have played a substantial role in driving the veterinary vaccine market, as governments worldwide prioritize safe medical practices for various animals, including communal and livestock species. Legislation addressing zoonotic pathogens is in effect in both developed and developing nations, recognizing the potential severe economic consequences of an outbreak on a nation's gross domestic product (GDP). Measures to mitigate these risks include culling infected animals and maintaining adequate vaccine stockpiles with updated strains. The dynamic growth observed in the animal sector, driven by increasing demand for products such as milk, chicken eggs, meat, and fabric, has attracted significant investment in advanced machinery and modern technologies. Preventive measures against FMD, such as vaccination, are deemed crucial interventions by governments and private stakeholders in the animal industry, given the substantial financial losses associated with disease outbreaks. The absence of a definitive cure underscores the importance of vaccination, particularly considering the various means through which infection can occur. In developing countries where livestock production significantly contributes to GDP, animal healthcare practices receive considerable attention. Government organizations in these nations prioritize the development of new medications and vaccination programs to safeguard cattle health. Conversely, regions with stringent measures and restrictions on animal movement, particularly in affluent areas like North America and Europe, have effectively minimized FMD outbreaks and thus have reduced reliance on FMD vaccines.

Top-down and bottom-up approaches were used to estimate and validate the size of the global FMD disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global FMD Disease Market Segmental Analysis

The global FMD disease market is segmented based on technique, animal type, and region. By technique, the market is segmented into conventional vaccines (aluminum hydroxide/saponin-based vaccines, oil-based vaccines), and emergency vaccines. By animal type, the market is segmented into cattle, sheep and goat, pigs, others (antelope, deer, bison, and camelids). By region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global FMD Disease Market

The increasing demand for animal protein and dairy products serves as a significant catalyst for the Foot-and-Mouth Disease (FMD) market, given the potential for substantial losses within the livestock industry caused by FMD outbreaks.

Restraints in the Global FMD Disease Market

The substantial expenses associated with FMD vaccines and diagnostic tests represent a significant barrier to the FMD market, especially in developing nations with extensive livestock populations.

Market Trends of the Global FMD Disease Market

A prominent market trend is the rising demand for Foot-and-Mouth Disease (FMD) vaccines, especially evident in developing nations. Governments worldwide are implementing initiatives to mitigate and prevent FMD outbreaks, thereby fueling the demand for FMD vaccines.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global FMD Disease Market by Technique

Market Overview
Conventional Vaccines (Aluminum Hydroxide/Saponin-based Vaccines
Oil-based Vaccines)
and Emergency Vaccines

Global FMD Disease Market by Animal Type

Market Overview
Cattle
Sheep and goat
Pigs
and Others (antelope
deer
bison
and camelids)

Global FMD Disease Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

MSD Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zoetis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indian Immunologicals Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biogenesis-Bago
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ceva SantA(C) Animale
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
China Animal Husbandry Co., Ltd. (CAH)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guangdong Dahuanong Animal Health Products Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Heska Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indian Immunologicals Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lanzhou Veterinary Research Institute
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Limor de Colombia S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merial (Sanofi)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Minnesota Veterinary Diagnostic Laboratory
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PVT-Polish Veterinary Pharmaceuticals Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RAKARB Veterinary Biotech.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vecol S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VA(C)toquinol
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioveta a.s.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments